Cargando…
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
Prostate cancer (PCa) is the second most common malignancy among men in the world. Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which develops upon resistance to first line androgen deprivation therapy (ADT). Emerging evidence demonstrates a key role for the PI3K-AK...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023363/ https://www.ncbi.nlm.nih.gov/pubmed/24759575 http://dx.doi.org/10.4103/1008-682X.122876 |